Tobias Meißner
- Hematology top 2%
- Multiple Myeloma Research and Treatments 25
- Periodontics top 5%
- Oncology top 10%
-
- Cancer Genomics and Diagnostics 14
-
- Nanoparticles: synthesis and applications 12
-
- Diabetes Management and Research 6
-
- Environmental remediation with nanomaterials 5
-
- Protein Degradation and Inhibitors 5
-
- Pancreatic function and diabetes 5
-
- Diabetes and associated disorders 4
- Co-authors
- Annegret PotthoffDana KühnelDirk HoseWibke BuschHartmut GoldschmidtVolkmar RichterArmin SpringerBernard Klein
- Cited by
- HematologyPeriodonticsOncology
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Tobias Meißner
78 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 139
- Hematology 401
- Periodontics 67
- Oncology 284
- Cancer Research 126
- Health, Toxicology and Mutagenesis 109
Countries citing papers authored by Tobias Meißner
This map shows the geographic impact of Tobias Meißner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Meißner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Meißner more than expected).
Fields of papers citing papers by Tobias Meißner
This network shows the impact of papers produced by Tobias Meißner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Meißner. The network helps show where Tobias Meißner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tobias Meißner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 21 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 24 | |
| 6 | 2016 | 21 | |
| 7 | 2015 | 44 | |
| 8 | 2015 | 15 | |
| 9 | 2015 | 4 | |
| 10 | miRNAs in multiple myeloma â a survival relevant complex regulator of gene expression | 2015 | 5 |
| 11 | 2014 | 28 | |
| 12 | 2014 | 20 | |
| 13 | 2014 | 27 | |
| 14 | 2013 | 21 | |
| 15 | 2012 | 7 | |
| 16 | 2011 | 30 | |
| 17 | 2011 | 34 | |
| 18 | 2010 | 6 | |
| 19 | 2009 | 62 | |
| 20 | 2008 | 110 |
About Tobias Meißner
Tobias Meißner is a scholar working on Hematology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 83 papers that have together received 1.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (25 papers), Cancer Genomics and Diagnostics (14 papers), Nanoparticles: synthesis and applications (12 papers), Diabetes Management and Research (6 papers), Environmental remediation with nanomaterials (5 papers), Protein Degradation and Inhibitors (5 papers), Pancreatic function and diabetes (5 papers) and Diabetes and associated disorders (4 papers). The work is most often cited by research in Hematology (401 citations), Periodontics (67 citations) and Oncology (284 citations). Tobias Meißner has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Annegret Potthoff, Dana Kühnel, Dirk Hose, Wibke Busch, Hartmut Goldschmidt, Volkmar Richter, Armin Springer, Bernard Klein, Thierry Rème and Kristin Schirmer. Their work appears in journals such as Nature Communications, Blood and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.